VH298

N/A

Report date: 2023/02/22 11:00:58
NME

Base Information

Drug NameVH298
Drug Alias NameVH298VH-298
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of Actionvon Hippel-Lindau disease tumor suppressor degraders
Targetsvon Hippel-Lindau disease tumor suppressor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of DundeeCellzome Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesCellzome GmbhUniversity Of Dundee
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A